143 related articles for article (PubMed ID: 35209006)
1. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova M; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209006
[TBL] [Abstract][Full Text] [Related]
2. Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from
Suleimen YM; Jose RA; Suleimen RN; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408682
[TBL] [Abstract][Full Text] [Related]
3. Jusanin, a New Flavonoid from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268738
[TBL] [Abstract][Full Text] [Related]
4.
Alesawy MS; Elkaeed EB; Alsfouk AA; Metwaly AM; Eissa IH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34771004
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
[TBL] [Abstract][Full Text] [Related]
6. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
Li D; Luan J; Zhang L
Biochem Biophys Res Commun; 2021 Jan; 538():72-79. PubMed ID: 33276953
[TBL] [Abstract][Full Text] [Related]
8. The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach.
Elkaeed EB; Khalifa MM; Alsfouk BA; Alsfouk AA; El-Attar AMM; Eissa IH; Metwaly AM
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422263
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation.
Sohraby F; Aryapour H
PLoS One; 2021; 16(5):e0251910. PubMed ID: 34010326
[TBL] [Abstract][Full Text] [Related]
10. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.
Shan H; Liu J; Shen J; Dai J; Xu G; Lu K; Han C; Wang Y; Xu X; Tong Y; Xiang H; Ai Z; Zhuang G; Hu J; Zhang Z; Li Y; Pan L; Tan L
Cell Chem Biol; 2021 Jun; 28(6):855-865.e9. PubMed ID: 33979649
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B
SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of phytoconstituents from miracle herb
Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA
J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456
[TBL] [Abstract][Full Text] [Related]
13.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
14. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.
Elzupir AO
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946540
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2.
Elekofehinti OO; Iwaloye O; Josiah SS; Lawal AO; Akinjiyan MO; Ariyo EO
Mol Divers; 2021 Aug; 25(3):1761-1773. PubMed ID: 33201386
[TBL] [Abstract][Full Text] [Related]
17. Isolation and
Wanas AS; Radwan MM; Marzouk AA; Elkaeed EB; Alsfouk BA; Mostafa AE; Eissa IH; Metwaly AM; ElSohly MA
Nat Prod Res; 2023 Dec; ():1-14. PubMed ID: 38100380
[TBL] [Abstract][Full Text] [Related]
18. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
[TBL] [Abstract][Full Text] [Related]
19. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
20. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.
Kavitha K; Sivakumar S; Ramesh B
Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]